LCT bought in at 6.6, sold at 8.3.
It's a good ann. but needs years more work to become anything worthwhile. Don't get me wrong, it's an amazing achievement, but from a science perspective 4 patients is nowhere near enough data to begin 'curing'.
The method of their testing was quite amazing though, very unique methods used.
Coming from my Microbiologist partner: "Great start, but has a very very long way to go. 4 people is no way near enough to get started on any kind of resolution to parkinsons, it will take maybe another 6-8 years to get there with more testing" after reading the ann.
Daytrading June 7 afternoon, page-122
-
- There are more pages in this discussion • 111 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)